Inhibikase Therapeutics Income Statement (2020-2025) | IKT

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Revenue & cost
Revenue 0.27M0.22M0.04M0.17M1.41M1.36M0.33M0.00M0.05M0.01M0.01M0.06M0.06M0.12M0.08M1.00
Operating items
Research & Development 0.28M0.26M0.12M0.23M2.43M2.38M3.15M3.39M3.02M2.98M2.98M3.05M2.85M4.54M3.23M3.00M2.75M3.08M4.19M7.19M
Selling, General & Administrative 0.53M0.37M0.58M1.14M1.60M1.61M1.64M1.65M1.67M1.66M1.54M1.34M1.93M1.78M1.62M1.40M2.03M1.97M1.64M5.74M
Operating Expenses 0.81M0.63M0.70M1.37M4.03M3.99M4.80M5.04M4.69M4.65M4.52M4.40M4.78M6.32M4.85M4.40M4.78M5.05M5.83M12.93M
Operating Income -0.54M-0.41M-0.66M-1.20M-2.63M-2.63M-4.47M-5.04M-4.64M-4.64M-4.51M-4.33M-4.71M-6.20M-4.77M-4.40M-4.78M-5.05M-5.83M-12.93M
EBIT -0.54M-0.41M-0.66M-1.20M-2.63M-2.63M-4.47M-5.04M-4.64M-4.64M-4.51M-4.33M-4.71M-6.20M-4.77M-4.40M-4.78M-5.05M-5.83M-12.93M
Non-operating items
Non Operating Investment Income 0.03M0.06M0.00M
Interest & Investment Income 0.02M
Net income details
EBT -0.55M-0.42M-0.67M-1.21M-2.64M-2.64M-4.47M-5.04M-4.64M-4.64M-4.49M-4.33M-4.71M-6.20M-4.77M-4.40M-4.78M-5.05M-5.83M-12.93M
Profit After Tax -0.55M-0.42M-0.67M-1.21M-2.64M-2.64M-4.47M-5.04M-4.64M-4.64M-4.49M-4.28M-4.48M-5.78M-4.60M-4.18M-4.65M-4.96M-5.78M-12.13M
Income from Continuing Operations -0.55M-0.42M-0.67M-1.21M-2.64M-2.64M-4.47M-5.04M-4.64M-4.64M-4.49M-4.33M-4.71M-6.20M-4.77M-4.40M-4.78M-5.05M-5.83M-12.93M
Consolidated Net Income -0.55M-0.42M-0.67M-1.21M-2.64M-2.64M-4.47M-5.04M-4.64M-4.64M-4.49M-4.33M-4.71M-6.20M-4.77M-4.40M-4.78M-5.05M-5.83M-12.93M
Income towards Parent Company -0.55M-0.42M-0.67M-1.21M-2.64M-2.64M-4.47M-5.04M-4.64M-4.64M-4.49M-4.33M-4.71M-6.20M-4.77M-4.40M-4.78M-5.05M-5.83M-12.93M
Net Income towards Common Stockholders -0.55M-0.42M-0.67M-1.21M-2.64M-2.64M-4.47M-5.04M-4.64M-4.64M-4.49M-4.33M-4.71M-6.20M-4.77M-4.40M-4.78M-5.05M-5.83M-12.93M
Additional items
EPS (Basic) -0.07-0.05-0.08-0.15-0.26-0.22-0.18-0.20-0.18-1.10-1.06-1.02-0.98-1.11-0.75-0.68-0.73-0.66-0.650.87
EPS (Weighted Average and Diluted) -0.25-0.18-0.20-0.18-1.10-1.06-1.02-0.98-1.11-0.75-0.68-0.73-0.66-0.650.87
Shares Outstanding (Weighted Average) 1.60M1.60M1.60M1.60M1.68M3.02M4.19M4.19M4.20M4.20M4.20M4.20M4.83M5.18M5.35M6.17M6.48M6.48M7.46M67.19M74.34M74.34M74.52M
Shares Outstanding (Diluted Average) 12.24M25.14M18.21M25.21M4.22M4.22M4.22M5.58M6.16M6.16M6.03M6.34M7.54M8.88M23.71M89.54M90.01M90.05M
EBITDA -0.54M-0.41M-0.66M-1.20M-2.63M-2.63M-4.47M-5.04M-4.64M-4.64M-4.47M-4.33M-4.71M-4.42M-4.59M-4.40M-4.78M-5.05M-5.83M-12.93M
Interest Expenses 0.01M0.01M0.01M0.01M0.01M0.01M157.00158.005.00